Abstract
The review article by Petri et al. stresses the need of pre-symptomatic screening for arrhythmia and heart failure in patients with myotonic dystrophy type 1 (MD1) [1]. The authors propose to screen every patient by ECG, 48-hour Holter monitoring and transthoracic echocardiography at the time of diagnosis. Follow-up in asymptomatic patients should be performed by ECG and Holter monitoring every second year and by transthoracic echocardiography every third year. Patients with symptoms suggestive of arrhythmia should undergo event monitoring and possibly invasive electrophysiological studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
